// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

The impact of persistence of cytogenetic abnormalities pre‐transplantation in AML and MDS – a single UK centre retrospective review

S Sivakumaran - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Full donor whole bone marrow (WBM) Chimerism at 3 months and the Day +30 absolute lymphocyte count (ALC) predict superior overall survival (OS) in reduced/intermediate intensity (RIC) Alemtuzumab‐based allografts for lymphomas

A Kanellopoulos - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Alemtuzumab

Introducing ‘TacroCalc’: a tacrolimus dose calculator for android and iOS that promotes therapeutic tacrolimus dosing following allogeneic stem cell transplantation

T Mahendiran - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Cyclosporine eent

Pre thawed fresh frozen plamsa: implementation in a Major Trauma Centre

K Feane - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Octaplas

Severe haemolytic disease of newborn due to anti‐C and anti‐G

S Kazi - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

Fibrinogen (IV)

IV iron: the results of the West Midlands regional transfusion committee survey

A Harris - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

Ferric carboxymaltose

Transfusion education: can using social media help improve training? The West Midlands experience

G Mayer - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Development and pilot testing of a Patient Blood Management App to guide junior doctor clinical decision making on red cell transfusions in non bleeding adult patients – results of accuracy study

A Dhesi - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Time to refine transfusion associated circulatory overload (TACO)

SL Grey - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Hypofibrinogenemia in adults and children undergoing plasma exchange: how much of a problem is it and are we monitoring it appropriately?

C Watson - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Human serum albumin

Patient blood management (PBM) can be effectively employed to reduce the RBC units usage in cancer patients

M Mamat - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Maternal red cell antibodies: incidence and outcomes from a single‐centre in North London

R Pocock - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Allopurinol

ABO‐incompatible transfusions – nearly 300 prevented by staff vigilance in 2015

P Bolton-Maggs - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

“Low platelet usage” haematology laboratories: to store or not to store?

M Elmi - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Granulocyte transfusions: results from a national survey and a proposal for a prospective registry

S Morton - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A quality improvement project which initiated a change in practice and several million pounds worth of savings to the NHS

J Birchall - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

N/A

Errors in and complications of paediatric transfusion: SHOT 2015

HV New - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

A prospective study to estimate the full costs of administering blood transfusions in the UK

E Stokes - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Compliance of post‐transfusion platelet count testing following HLA‐matched platelet transfusions

P Polzella - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Risk factors for death in patients who have received massive transfusion, following cardiac surgery over a three year period at Barts Health NHS Trust

M Garner - British Society for Hematology (BSH) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved